| Metric | შპს BROTHERS | შპს ფარმაქსი |
|---|---|---|
| Growth | ||
| Revenue | ₾30.1m₾32.3m | ₾37.2m₾38.4m |
| Revenue growth | -6.8% | -2.9% |
| Profitability | ||
| EBITDA | -₾575k₾3.9m | ₾2.3m₾4.9m |
| EBITDA margin | -1.9%12.2% | 6.1%12.8% |
| Net profit | -₾4.4m₾9.9m | ₾188k₾5.6m |
| Net margin | -14.6%30.5% | 0.5%14.6% |
| Balance sheet | ||
| Total assets | ₾36.8m₾38.8m | ₾53.9m₾85.6m |
| Total equity | -₾43.1m-₾38.7m | ₾17.6m₾28.0m |
| ROE | — | 1.1%20.0% |